Table 3.
Analyses of secondary outcomes for ApoA-I in cancers.
| Secondary outcomes | No. of studies | No. of cases | Pooled HR (95% CI) | p value | Heterogeneity | |
|---|---|---|---|---|---|---|
| I 2 (%) | Model | |||||
| CSS | 2 | 1666 | 0.47 (0.19–0.76) | <0.001 | 77.5 | Random |
| TTR | 2 | 443 | 0.43 (0.29–0.58) | <0.001 | 0.0 | Fixed |
| LRFS | 2 | 3123 | 0.58 (0.42–0.74) | <0.001 | 0.0 | Fixed |
| DMFS | 2 | 3123 | 0.65 (0.41–0.89) | <0.001 | 73.0 | Random |
| DFS | 4 | 3962 | 0.64 (0.43–0.84) | <0.001 | 65.9 | Random |